Company Filing History:
Years Active: 2016-2018
Title: Innovations of Hans Georg Fliri
Introduction
Hans Georg Fliri is a notable inventor based in Ongar, GB. He has made significant contributions to the field of pharmaceutical sciences, particularly through his innovative patents. With a total of 3 patents, Fliri's work focuses on compounds that have the potential to improve health outcomes.
Latest Patents
Fliri's latest patents include groundbreaking inventions such as cyclic depsipeptide compounds and their uses. This invention relates to novel cycloundecadepsipeptide compounds and their analogues, which bind and inhibit cyclophilins. These compounds exhibit reduced immunosuppressive activity and improved physicochemical properties, including water solubility. Additionally, he has developed protected succinates for enhancing mitochondrial ATP production. This patent discloses mono or di-succinate compounds where one or both of the acid groups in the succinate core are protected in the form of biologically labile moieties, aimed at enhancing mitochondrial function.
Career Highlights
Throughout his career, Fliri has worked with various companies, including Cypralis Limited and Neurovive Pharmaceuticals AB. His work in these organizations has contributed to advancements in drug development and therapeutic applications.
Collaborations
Fliri has collaborated with notable individuals in his field, including Rhonan Lee Ford and Antonio Kuok Keong Vong. These collaborations have likely enriched his research and innovation efforts.
Conclusion
Hans Georg Fliri's contributions to the field of pharmaceuticals through his patents demonstrate his commitment to advancing medical science. His innovative work continues to have a significant impact on health and wellness.